Abstract:
A tissue anchor has a body, protrusions from the body, and a tissue engaging fin. The body is oriented on a longitudinal axis and has a leading tip, a leading end portion extending from the leading tip, a trailing end portion connected to the leading end portion, with the trailing end portion terminating in a trailing tip that is located opposite of the leading tip. A first anchor width measured between the protrusions is greater than a second anchor width measured at the trailing end portion of the body. The tissue engaging fin is integrated with the leading end portion of the body and oriented in a direction perpendicular to the radial direction of the first and second protrusions. The tissue engaging fin has a fin width and is provided with an eyelet formed through the fin width. A gripping tab is removably attached to the tissue engaging fin.
Abstract:
A tissue anchor has a body, protrusions from the body, and a tissue engaging fin. The body is oriented on a longitudinal axis and has a leading tip, a leading end portion extending from the leading tip, a trailing end portion connected to the leading end portion, with the trailing end portion terminating in a trailing tip that is located opposite of the leading tip. A first anchor width measured between the protrusions is greater than a second anchor width measured at the trailing end portion of the body. The tissue engaging fin is integrated with the leading end portion of the body and oriented in a direction perpendicular to the radial direction of the first and second protrusions. The tissue engaging fin has a fin width and is provided with an eyelet formed through the fin width. A gripping tab is removably attached to the tissue engaging fin.
Abstract:
An attachment assembly configured to secure an implantable support within a patient includes a length of suture, an anchor, a capsule, and a clasp. The suture has a leading end half terminating in a leading end and a trailing end half terminating in a trailing end. The anchor is coupled to the trailing end half of the length of the suture. The capsule is attached to the leading end of the suture and has a through-bore extending longitudinally through the capsule. The clasp is attached to the trailing end of the suture, the clasp attachable to the implantable support.
Abstract:
A tissue anchor has a body, protrusions from the body, and a tissue engaging fin. The body is oriented on a longitudinal axis and has a leading tip, a leading end portion extending from the leading tip, a trailing end portion connected to the leading end portion, with the trailing end portion terminating in a trailing tip that is located opposite of the leading tip. A first anchor width measured between the protrusions is greater than a second anchor width measured at the trailing end portion of the body. The tissue engaging fin is integrated with the leading end portion of the body and oriented in a direction perpendicular to the radial direction of the first and second protrusions. The tissue engaging fin has a fin width and is provided with an eyelet formed through the fin width. A gripping tab is removably attached to the tissue engaging fin.
Abstract:
An artificial urinary sphincter system has a pressure reservoir attachable to a pump and a conduit attachable between the pump and a cuff. The cuff is formed as a one-piece monolithic polymer structure that is substantially circular in radial cross-section. The cuff has an interior wall connected by a pair of opposing end walls to an exterior wall and includes a closed cavity located between the interior wall and the exterior wall. The cuff has a part line that allows for placement of the cuff around a urethra of a user.
Abstract:
An incontinence treatment device has a solid rod connected between a proximal portion and a distal portion. The proximal portion is insertable into a urinary bladder. The solid rod is configured for placement in the urethra. The solid rod has a length that adapts the distal portion to be positioned outside and distal to the urethra with the proximal portion positioned in the urinary bladder. The proximal portion has a lateral dimension that is at least a factor of 3 greater than a lateral dimension of the solid rod and is so configured to block a neck of the urinary bladder and impede flow of urine out of the urinary bladder. A force applied to the distal portion displaces the proximal portion away from the neck of the urinary bladder to allow urine to exit the urinary bladder.
Abstract:
A Peyronie's treatment implant includes a skeletal framework having reinforcing components. Also included are one or more sheath components that are attached to the reinforcing components to provide support for penile tissue. The skeletal framework of the implant allows for elongation of the implant during erection of the penis and for contraction of the implant when the penis is returning to its flaccid state. Also included is at least one attachment mechanism for securing the implant to the penis, the attachment mechanism having a needle for penetrating through the targeted penile tissue and at least one anchor for attachment to the penile tissue.